HomeHNSPF • OTCMKTS
add
Hansoh Pharmaceutical Group Company Ltd
Nakaraang pagsara
$3.00
Sakop ng taon
$1.95 - $5.58
Market cap
145.41B HKD
Average na Volume
83.00
P/E ratio
-
Dividend yield
-
Primary exchange
HKG
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (CNY) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 2.88B | 2.91% |
Gastos sa pagpapatakbo | 1.96B | 13.70% |
Net na kita | 823.15M | -17.22% |
Net profit margin | 28.60 | -19.57% |
Kita sa bawat share | — | — |
EBITDA | 737.92M | -18.70% |
Aktuwal na % ng binabayarang buwis | 16.30% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (CNY) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 23.42B | -5.89% |
Kabuuang asset | 31.66B | -4.18% |
Kabuuang sagutin | 2.98B | -58.89% |
Kabuuang equity | 28.68B | — |
Natitirang share | 5.93B | — |
Presyo para makapag-book | 0.62 | — |
Return on assets | 5.15% | — |
Return on capital | 5.67% | — |
Cash Flow
Net change in cash
| (CNY) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 823.15M | -17.22% |
Cash mula sa mga operasyon | 589.99M | -40.11% |
Cash mula sa pag-invest | -1.88B | -11,815.45% |
Cash mula sa financing | -934.81M | -165.86% |
Net change in cash | -2.24B | -458.12% |
Malayang cash flow | 446.13M | -19.18% |
Tungkol
Hansoh Pharmaceutical Group Company Limited is a pharmaceutical company that manufactures and sells various types of medicine in mainland China. It was founded in 1995 in Lianyungang, Jiangsu Province, China, by Zhong Huijuan, who is the company's chair. Zhong and her family own 66% of the company. It is the largest psychotropic drug producer in China.
Hansoh Pharmaceutical had an initial public offering on the main board of the Hong Kong Stock Exchange on 14 June 2019.
In August 2022, it was announced that the company's stock would be added to the Hang Seng Index. Wikipedia
Itinatag
1995
Website
Mga Empleyado
8,989
